{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:43:24Z","timestamp":1768005804253,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Department of Clinical Cannabinoid Research"},{"name":"The University of Tokyo Graduate School of Medicine"},{"name":"Japan Cosmetic Association"},{"name":"Japan Federation of Medium and Small Enterprise Organizations"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To identify and characterize undescribed systemic sclerosis (SSc)-specific autoantibodies targeting nucleolar antigens and to assess their clinical significance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted proteome-wide autoantibody screening (PWAS) against serum samples from SSc patients with nucleolar patterned anti-nuclear antibodies (NUC-ANAs) of specific antibodies (Abs) unknown, utilizing wet protein arrays fabricated from in vitro human proteome. Controls included SSc patients with already-known SSc-specific autoantibodies, patients with other connective tissue diseases and healthy subjects. The selection of nucleolar antigens was performed by database search in the Human Protein Atlas. The presence of autoantibodies was certified by immunoblots and immunoprecipitations. Indirect immunofluorescence assays on HEp-2 cells were also conducted. Clinical assessment was conducted by retrospective review of electronic medical records.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>PWAS identified three candidate autoantibodies, including anti-nuclear valosin-containing protein-like (NVL) Ab. Additional measurements in disease controls revealed that only anti-NVL Abs are exclusively detected in SSc. Detection of anti-NVL Abs was reproduced by conventional assays such as immunoblotting and immunoprecipitation. Indirect immunofluorescence assays demonstrated homogeneous nucleolar patterns. Anti-NVL Ab-positive cases were characterized by significantly low prevalence of diffuse skin sclerosis and interstitial lung disease, compared with SSc cases with NUC-ANAs other than anti-NVL Abs, such as anti-U3-RNP and anti-Th\/To Abs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Anti-NVL Ab is an SSc-specific autoantibody associated with a unique combination of clinical features, including limited skin sclerosis and lack of lung involvement.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae063","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T02:03:35Z","timestamp":1706666615000},"page":"2865-2873","source":"Crossref","is-referenced-by-count":11,"title":["Autoantibodies to nuclear valosin-containing protein-like protein: systemic sclerosis-specific antibodies revealed by <i>in vitro<\/i> human proteome"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6755-8047","authenticated-orcid":false,"given":"Kazuki M","family":"Matsuda","sequence":"first","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Kotani","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"ProteoBridge Corporation , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Ono","sequence":"additional","affiliation":[{"name":"ProteoBridge Corporation , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Okumura","sequence":"additional","affiliation":[{"name":"ProteoBridge Corporation , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ogawa","sequence":"additional","affiliation":[{"name":"ProteoBridge Corporation , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Miya","sequence":"additional","affiliation":[{"name":"ProteoBridge Corporation , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Sato","sequence":"additional","affiliation":[{"name":"ProteoBridge Corporation , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Uchino","sequence":"additional","affiliation":[{"name":"NOV Academic Research, TOKIWA Pharmaceutical Co., Ltd , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murakami","family":"Yumi","sequence":"additional","affiliation":[{"name":"NOV Academic Research, TOKIWA Pharmaceutical Co., Ltd , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsunaka","sequence":"additional","affiliation":[{"name":"NOV Academic Research, TOKIWA Pharmaceutical Co., Ltd , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Norimatsu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruyoshi","family":"Hisamoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruriko","family":"Kawanabe","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Kuzumi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemichi","family":"Fukasawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Yoshizaki-Ogawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Shoda","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-5254","authenticated-orcid":false,"given":"Keishi","family":"Fujio","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kanazawa University Graduate School of Medical Sciences , Ishikawa,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Goshima","sequence":"additional","affiliation":[{"name":"ProteoBridge Corporation , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-9140","authenticated-orcid":false,"given":"Ayumi","family":"Yoshizaki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]},{"name":"Department of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"2024100107515071400_keae063-B1","first-page":"1","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"2024100107515071400_keae063-B2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12016-022-08946-w","article-title":"Systemic sclerosis-specific antibodies: novel and classical biomarkers","volume":"64","author":"Cavazzana","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024100107515071400_keae063-B3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","article-title":"Autoantibodies as predictive tools in systemic sclerosis","volume":"6","author":"Nihtyanova","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2024100107515071400_keae063-B4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2024100107515071400_keae063-B5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","article-title":"Antinuclear Antibodies in Systemic Sclerosis\u202f: an Update","volume":"58","author":"Stochmal","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024100107515071400_keae063-B6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","article-title":"The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis","volume":"42","author":"Hesselstrand","year":"2003","journal-title":"Rheumatology"},{"key":"2024100107515071400_keae063-B7","first-page":"2050","article-title":"Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement","volume":"34","author":"Nishimagi","year":"2007","journal-title":"J Rheumatol"},{"key":"2024100107515071400_keae063-B8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24409","article-title":"Anti-U3 RNP autoantibodies in systemic sclerosis","volume":"60","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2024100107515071400_keae063-B9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.revmed.2019.12.020","article-title":"Characteristics of Systemic Sclerosis patients with positive anti-Th\/To antibodies: about 6 patients and literature review","volume":"41","author":"Muller","year":"2020","journal-title":"Rev Med Interne"},{"key":"2024100107515071400_keae063-B10","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1093\/rheumatology\/keab152","article-title":"The clinical phenotype of systemic sclerosis patients with anti-PM\/Scl antibodies: results from the EUSTAR cohort","volume":"60","author":"Lazzaroni","year":"2021","journal-title":"Rheumatol"},{"key":"2024100107515071400_keae063-B11","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3899\/jrheum.100316","article-title":"Anti-Th\/To are common antinucleolar autoantibodies in Italian patients with scleroderma","volume":"37","author":"Ceribelli","year":"2010","journal-title":"J Rheumatol"},{"key":"2024100107515071400_keae063-B12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nmeth.1273","article-title":"Human protein factory for converting the transcriptome into an in vitro-expressed proteome","volume":"5","author":"Goshima","year":"2008","journal-title":"Nat Methods"},{"key":"2024100107515071400_keae063-B13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/gtc.12832","article-title":"Identification and characterization of the antigen recognized by the germ cell mAb TRA98 using a human comprehensive wet protein array","volume":"26","author":"Fukuda","year":"2021","journal-title":"Genes to Cells"},{"key":"2024100107515071400_keae063-B14","doi-asserted-by":"crossref","first-page":"893086","DOI":"10.3389\/fimmu.2022.893086","article-title":"Autoantibody Landscape Revealed by Wet Protein Array\u202f: Sum of Autoantibody Levels Re fl ects Disease Status","volume":"13","author":"Matsuda","year":"2022","journal-title":"Front Immunol"},{"key":"2024100107515071400_keae063-B15","doi-asserted-by":"crossref","first-page":"1255540","DOI":"10.3389\/fimmu.2023.1255540","article-title":"Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array","volume":"14","author":"Kuzumi","year":"2023","journal-title":"Front Immunol"},{"key":"2024100107515071400_keae063-B16","first-page":"1747","article-title":"2013 classification criteria for systemic sclerosis: an american college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2024100107515071400_keae063-B17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2024100107515071400_keae063-B18","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2024100107515071400_keae063-B19","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2024100107515071400_keae063-B20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13075-019-1919-6","article-title":"Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study","volume":"21","author":"Matsuda","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2024100107515071400_keae063-B21","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.1073\/pnas.232580399","article-title":"A cell-free protein synthesis system for high-throughput proteomics","volume":"99","author":"Sawasaki","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024100107515071400_keae063-B22","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3321","article-title":"A subcellular map of the human proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"key":"2024100107515071400_keae063-B23","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"2024100107515071400_keae063-B24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns (ICAP) 2014-2015","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol"},{"key":"2024100107515071400_keae063-B25","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2024100107515071400_keae063-B26","doi-asserted-by":"crossref","first-page":"102988","DOI":"10.1016\/j.jaut.2022.102988","article-title":"Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis","volume":"135","author":"Vulsteke","year":"2023","journal-title":"J Autoimmun"},{"key":"2024100107515071400_keae063-B27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/geno.1997.4856","article-title":"NVL: a new member of the AAA family of ATPases localized to the nucleus","volume":"44","author":"Germain-Lee","year":"1997","journal-title":"Genomics"},{"key":"2024100107515071400_keae063-B28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-3083.2006.01747.x","article-title":"Anti-p97\/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease?","volume":"63","author":"Miyachi","year":"2006","journal-title":"Scand J Immunol"},{"key":"2024100107515071400_keae063-B29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/acr2.11510","article-title":"Anti\u2013Valosin-Containing Protein (VCP\/p97) autoantibodies in inclusion body myositis and other inflammatory myopathies","volume":"5","author":"Amlani","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"2024100107515071400_keae063-B30","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1091\/mbc.e04-08-0692","article-title":"NVL2 is a nucleolar AAA-ATPase that interacts with ribosomal protein L5 through its nucleolar localization sequence","volume":"15","author":"Nagahama","year":"2004","journal-title":"Mol Biol Cell"},{"key":"2024100107515071400_keae063-B31","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.1780390712","article-title":"Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serologic, and clinical analysis","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2024100107515071400_keae063-B32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbrc.2015.07.032","article-title":"NVL2, a nucleolar AAA-ATPase, is associated with the nuclear exosome and is involved in pre-rRNA processing","volume":"464","author":"Yoshikatsu","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"2024100107515071400_keae063-B33","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.bbrc.2011.12.101","article-title":"The AAA-ATPase NVL2 is a telomerase component essential for holoenzyme assembly","volume":"417","author":"Her","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"2024100107515071400_keae063-B34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molcel.2009.05.016","article-title":"RVB1\/RVB2: running rings around molecular biology","volume":"34","author":"Jha","year":"2009","journal-title":"Mol Cell"},{"key":"2024100107515071400_keae063-B35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/35088000","article-title":"Structure of the Ku heterodimer bound to dna and its implications for double-strand break repair","volume":"412","author":"Walker","year":"2001","journal-title":"Nature"},{"key":"2024100107515071400_keae063-B36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0074-7696(06)51005-8","article-title":"Cell and molecular biology of the exosome: how to make or break an RNA","volume":"251","author":"Schilders","year":"2006","journal-title":"Int Rev Cytol"},{"key":"2024100107515071400_keae063-B37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians?","volume":"9","author":"Didier","year":"2018","journal-title":"Front Immunol"},{"key":"2024100107515071400_keae063-B38","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/art.30539","article-title":"Immunization with DNA topoisomerase I and Freund\u2019s complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling","volume":"63","author":"Yoshizaki","year":"2011","journal-title":"Arthritis Rheumatol"},{"key":"2024100107515071400_keae063-B39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol"},{"key":"2024100107515071400_keae063-B40","doi-asserted-by":"crossref","first-page":"102995","DOI":"10.1016\/j.jaut.2023.102995","article-title":"Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening","volume":"135","author":"Matsuda","year":"2023","journal-title":"J Autoimmun"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae063\/56731572\/keae063.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae063\/59432300\/keae063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae063\/59432300\/keae063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T07:52:33Z","timestamp":1727769153000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/10\/2865\/7593763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,1,30]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae063","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,1,30]]}}}